ArticleJournal of analytical methods in chemistry2025
Multi-Index Quantitative Analysis of Pharyngiyan Tablet Characteristics by Screening Different Quality Control Components.
Article in Journal of analytical methods in chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pharyngiyan tablet is a traditional Chinese medicine (TCM) renowned for its efficacy in moisturizing the lungs, clearing the throat. However, it exhibits quality variations due to discrepancies in regulatory standards and challenges in comprehensive evaluation. In this study, ultra-performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS/MS) was used to qualitatively analyze the chemical composition of pharyngiyan tablets. Full composition analysis detected 131 chemical constituents. Gallic acid, paeoniflorin, rutin, baicalin, and harpagoside were identified as quality control (QC) indexes through rational screening. These indexes were selected based on their effectiveness in demonstrating differences, stability after processing, specificity, and cost-effectiveness in measurement. For the multimetric quality assessment of the five screening components, a high-performance liquid chromatography with diode array detector (HPLC-DAD) method with wavelength switching was developed. A total of 104 batches of samples from 10 manufacturers were included in the analyses. The content of each ingredient varied significantly across enterprises and batches, with certain enterprises characterized by inferior drug feeding, deviation from prescribed ingredient amounts, and nonstandardized feeding practices. Overall, aquality assessment method was established to provide a basis for the market regulation and quality assessment of pharyngiyan tablets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.